PUS1

pseudouridine synthase 1, the group of Pseudouridine synthases

Basic information

Region (hg38): 12:131929200-131945896

Links

ENSG00000177192NCBI:80324OMIM:608109HGNC:15508Uniprot:Q9Y606AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • myopathy, lactic acidosis, and sideroblastic anemia 1 (Moderate), mode of inheritance: AR
  • myopathy, lactic acidosis, and sideroblastic anemia (Supportive), mode of inheritance: AR
  • myopathy, lactic acidosis, and sideroblastic anemia 1 (Strong), mode of inheritance: AR
  • mitochondrial disease (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Myopathy, lactic acidosis, and sideroblastic anemia 1ARHematologicSevere, non-B6 responsive anemia has reportedly required transfusionsEndocrine; Hematologic; Musculoskeletal; Neurologic7726239; 14981724; 15108122; 15103716; 17056637; 19731322; 25227147

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PUS1 gene.

  • not provided (25 variants)
  • Myopathy, lactic acidosis, and sideroblastic anemia 1 (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PUS1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
261
clinvar
2
clinvar
263
missense
3
clinvar
118
clinvar
9
clinvar
130
nonsense
8
clinvar
7
clinvar
15
start loss
2
clinvar
2
frameshift
18
clinvar
13
clinvar
31
inframe indel
0
splice donor/acceptor (+/-2bp)
8
clinvar
8
splice region
4
26
30
non coding
14
clinvar
61
clinvar
12
clinvar
87
Total 26 33 132 331 14

Highest pathogenic variant AF is 0.00000657

Variants in PUS1

This is a list of pathogenic ClinVar variants found in the PUS1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-131929266-G-C Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 13, 2018)880945
12-131929270-C-T Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 12, 2018)307692
12-131929299-C-T Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 13, 2018)880946
12-131929436-G-C Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 13, 2018)307693
12-131929457-G-C Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 13, 2018)307694
12-131929477-G-A Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 12, 2018)307695
12-131929479-G-C Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 13, 2018)307696
12-131929541-C-T Myopathy, lactic acidosis, and sideroblastic anemia 1 Benign (Jun 14, 2018)307697
12-131929572-G-A Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 13, 2018)882302
12-131929643-G-A Myopathy, lactic acidosis, and sideroblastic anemia 1 Uncertain significance (Jan 13, 2018)882303
12-131929674-G-T not specified Likely benign (Jan 31, 2018)514445
12-131929677-A-G not specified Likely benign (Sep 06, 2017)384562
12-131929723-A-G Myopathy, lactic acidosis, and sideroblastic anemia 1 Conflicting classifications of pathogenicity (Jan 10, 2024)2146777
12-131929723-A-T Myopathy, lactic acidosis, and sideroblastic anemia 1 Likely pathogenic (Jun 17, 2024)3574397
12-131929724-T-G PUS1-related disorder • Myopathy, lactic acidosis, and sideroblastic anemia 1 Likely pathogenic (Feb 23, 2024)3032548
12-131929728-C-A Likely benign (Mar 11, 2024)2967937
12-131929728-C-T Likely benign (Sep 04, 2023)2963284
12-131929730-T-A Inborn genetic diseases Uncertain significance (Apr 23, 2024)2420294
12-131929731-C-G Likely benign (Mar 24, 2023)1147342
12-131929732-C-T Pathogenic (Nov 19, 2021)1361128
12-131929734-G-A Likely benign (Dec 10, 2022)2819926
12-131929739-G-A Uncertain significance (Apr 04, 2022)2121316
12-131929740-C-T Likely benign (Feb 26, 2024)1081900
12-131929742-C-T Inborn genetic diseases Uncertain significance (Oct 21, 2024)2080730
12-131929743-G-C Likely benign (Jul 26, 2019)1086876

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PUS1protein_codingprotein_codingENST00000376649 614662
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001670.9741257290121257410.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2912502630.9490.00001712758
Missense in Polyphen85106.140.800841133
Synonymous-0.1541231211.020.00000867861
Loss of Function1.98715.40.4556.57e-7193

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0001390.000139
European (Non-Finnish)0.00004470.0000440
Middle Eastern0.000.00
South Asian0.00006530.0000653
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts specific uridines to PSI in a number of tRNA substrates. Acts on positions 27/28 in the anticodon stem and also positions 34 and 36 in the anticodon of an intron containing tRNA. Involved in regulation of nuclear receptor activity through pseudouridylation of SRA1 RNA. {ECO:0000269|PubMed:24722331}.;
Pathway
tRNA modification in the nucleus and cytosol;tRNA processing;tRNA modification in the mitochondrion;Metabolism of RNA;Pyrimidine metabolism (Consensus)

Recessive Scores

pRec
0.134

Intolerance Scores

loftool
0.684
rvis_EVS
-0.75
rvis_percentile_EVS
13.58

Haploinsufficiency Scores

pHI
0.487
hipred
Y
hipred_score
0.565
ghis
0.599

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.940

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pus1
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
tRNA pseudouridine synthesis;mitochondrial tRNA pseudouridine synthesis;mRNA pseudouridine synthesis
Cellular component
nucleus;mitochondrion;mitochondrial matrix
Molecular function
tRNA binding;steroid receptor RNA activator RNA binding;RNA binding;pseudouridine synthase activity;tRNA pseudouridine synthase activity